|
Match
|
Document |
Document Title |
|
|
8440171 |
Composition and its physical requirements for eliminating odors in air
An air treating composition for eliminating odors from air in combination with specific spray valve and actuator requirements and spray performance parameters providing maximum dispersion of the...
|
|
|
8435497 |
Formoterol of and ciclesonide combination
The invention relates to pharmaceutical compositions containing combinations of formoterol and ciclesonide and the use of such pharmaceutical compositions in medicine, in particular, the...
|
|
|
8435547 |
Cream for stimulating mitochondrial activity in the skin
A skin care composition is useful for augmenting cellular metabolism in skin cells and thereby enhancing the regulation of intracellular signaling. The composition comprises a primer for skin cell...
|
|
|
8420058 |
Pharmaceutical aerosol composition
Compositions which contain an active ingredient, a propellant containing a hydrofluoroalkane (HFA), a co-solvent, and a low-volatility component are useful for administering the active ingredient...
|
|
|
8420059 |
Aerosol composition
A single phase aerosol composition comprising the following constituents: (a) 5 to 75 wt % of a hydrofluorocarbon(s) (HFC) of vapor pressure greater than or equal to 4 bar at 20° C. (60 psig at ...
|
|
|
8420060 |
Pharmaceutical aerosol formulations of formoterol and beclometasone dipropionate
Pharmaceutical formulations comprising beclometasone dipropionate and a salt of formoterol exhibit improved stability and are useful in pressurized metered dose inhalers (pMDIs).
|
|
|
8409549 |
Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections
A fosfomycin plus tobramycin combination formulation for delivery by aerosolization is described. The concentrated fosfomycin tobramycin combination formulation containing an efficacious amount of...
|
|
|
8404217 |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
Formulations are provided for pulmonary administration of an antifungal agent to a patient. Methods of using the formulations in the treatment of antifungal infections are also provided, including...
|
|
|
8398957 |
Aerosol compositions
An aerosol composition comprising: 0.01 wt % to 1.00 wt % sodium borate; 0.01 wt % to 1.50 wt % polyglycerol ester surfactant; <30 wt % propellant; and 67.5 wt % to 85.0 wt % water. Methods of...
|
|
|
8367734 |
Stable epinephrine suspension formulation with high inhalation delivery efficiency
A stable suspension aerosol formulation of epinephrine is suitable for administration through inhalation comprising a therapeutically effective amount of epinephrine, hydrofluorocarbon propellant,...
|
|
|
8361444 |
Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections
A fosfomycin plus tobramycin combination formulation for delivery by aerosolization is described. The concentrated fosfomycin tobramycin combination formulation containing an efficacious amount of...
|
|
|
8357352 |
Aerosol suspension formulations containing TG 227 ea or TG 134 a as propellant
Disclosed are propellant gas formulations containing at least one suspended active substance which contains chemically bound water, water and the propellant TG 227 or TG 134 a.
|
|
|
8354099 |
Skin-care compositions and uses thereof
Composition of a Dead Sea extract and at least one plant extract of a Himalayan origin are provided for topical applications.
|
|
|
8349297 |
Topical formulations
Saturated, monophasic solutions of drug in a solvent and propellant mixture, together with a film-forming agent, exhibit transdermal diffusion fluxes greater than those predicted by Fick's law when...
|
|
|
8349296 |
Aerosol foam composition
The present invention relates to aerosol foam composition for styling and conditioning keratin fibres especially human hair. The composition improves hair styling with excellent hold and especially...
|
|
|
8343945 |
Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
The present disclosure teaches unique formulations for topical administration of tetracycline antibiotics, in which the tetracycline antibiotics remain stable.
|
|
|
8337815 |
Pulmonary surfactant formulations
Synthetic pulmonary surfactant compositions comprising dipalmitoyl phosphatidylcholine, phosphatidylglycerol, and essentially neutral lipid, and having essentially no 1-palmitoyl 2-oleoyl...
|
|
|
8324266 |
Compositions, methods and systems for respiratory delivery of two or more active agents
Compositions, methods and systems are provided for pulmonary or nasal delivery of two or more active agents via a metered dose inhaler. In one embodiment, the compositions include a suspension...
|
|
|
8313732 |
Formoterol superfine formulation
A metal container and a method of preparing a metal container for a pharmaceutical formulation where the active ingredient is formoterol, a stereoisomer of formoterol, and a physiologically...
|
|
|
8309539 |
Acute treatment of social phobia
Methods and compositions for the treatment of social phobia are provided, including administering a therapeutically effective amount of an androsta-4,16-dien-3-ol steroid to an individual in need...
|
|
|
8309136 |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate or nanoparticulate active agent compositions
Disclosed are in vitro methods for evaluating the in vivo redispersibility of dosage forms of poorly water-soluble active agents. The methods utilize media representative of in vivo human...
|
|
|
8298515 |
Vitamin formulation
A pharmaceutical aerosol foam composition, comprising: an effective amount of a pharmaceutically active ingredient, wherein said pharmaceutically active ingredient is a vitamin or analogue thereof;...
|
|
|
8287841 |
Aerosol odor eliminating compositions containing alkylene glycol(s)
Aerosol odor eliminating compositions are described which are aqueous based and include at least one alkylene glycol, at least one surfactant wherein one or more of the at least one surfactant has...
|
|
|
8282909 |
Pharmaceutical composition for topical application of poorly soluble compounds
The present invention provides a formulation which contains a poorly water soluble pharmaceutically active compound at a concentration of 50 mg per 100 g formulation or above. The solubility is...
|
|
|
8277781 |
Device for intranasal administration
Disclosed herein are devices and processes for preparing a vial for an intranasal administration of a medicament where the vial comprises reduced oxygen content.
|
|
|
8277780 |
Stable liquid desoximethasone compositions with reduced oxidized impurity
The present invention relates to a stable liquid formulation comprising desoximetasone, isopropyl myristate, a C2-C4 alcohol and a stabilizing agent. Specifically, the present invention provides a...
|
|
|
8263044 |
Stilbene like compounds as novel HDAC inhibitors
The present invention relates to novel stilbene like compounds of the general formula (I), their derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates,...
|
|
|
8263580 |
Vitamin formulation
A pharmaceutical aerosol foam composition, comprising: an effective amount of a pharmaceutically active ingredient, wherein said pharmaceutically active ingredient is a vitamin or analogue thereof;...
|
|
|
8252268 |
Formoterol and mometasone aerosol formulations
A pharmaceutical aerosol formulation comprising particles of (a) formoterol or a pharmaceutically acceptable salt, solvate or physiologically functional derivative thereof and (b) mometasone or a...
|
|
|
8246934 |
Respiratory dispersion for metered dose inhalers comprising perforated microstructures
A respiratory dispersion for pulmonary delivery comprises one or more bioactive agents, a suspension medium, and a plurality of perforated microstructures having a mean aerodynamic diameter of less...
|
|
|
RE43580 |
Nasal calcitonin formulations
A liquid pharmaceutical composition is disclosed comprising calcitonin or an acid addition salt thereof and citric acid or salt thereof in a concentration from about to about 50 mM, said...
|
|
|
8235037 |
Drug condensation aerosols and kits
The present invention provides novel condensation aerosols for the treatment of disease and/or intermittent or acute conditions. These condensation aerosols have little or no pyrolysis degradation...
|
|
|
8236285 |
Buccal, polar and non-polar spray containing zolpidem
Buccal aerosol sprays or capsules using polar and non-polar solvents have now been developed which provide zolpidem for rapid absorption through the oral mucosa, resulting in fast onset of effect....
|
|
|
8231863 |
Continuous spray scalp therapy and dispensing systems for same
A spray delivery system in combination with a scalp medication is provided which includes a portable container having a gas imperious container wall, a pressure source disposed within the...
|
|
|
8211460 |
Formulations, devices and methods for treating and preventing mucositis
The present invention is directed to compositions, devices, and methods for non-irritatively treating and preventing mucositis, such as chronic rhinosinusitis (CRS). Some aspects of the invention...
|
|
|
8211449 |
Pharmaceutically elegant, topical anhydrous aerosol foam
A topical pharmaceutical aerosol foam containing liquid silicones to enhance cosmetic elegance. Although liquid silicones are inherent defoamers, a high quality, stable foam is produced.
|
|
|
8206687 |
Phospholipid-based inhalation system
The present invention includes a method for delivering medications deeper into the lungs and to the medications' pulmonary targets, which include bronchioles and alveoli. A first particularly...
|
|
|
8206688 |
Foam-forming composition
The present invention relates to a novel foam-forming composition suitable for rectal administration of locally-acting pharmaceutically active ingredients, and the product adapted to administer...
|
|
|
8192723 |
Aerosol composition
A single phase aerosol composition comprising the following constituents: (a) 5 to 75 wt % of a hydrofluorocarbon(s) (HFC) of vapour pressure greater than or equal to 4 bar at 20° C. (60 psig at ...
|
|
|
8187574 |
Intermittent injection aerosol product for skin
The present invention is directed to an intermittent aerosol dispensing device, for application of a product to skin of a human being, where the aerosol dispensing device includes an intermittent...
|
|
|
8182791 |
Formulations for use in inhaler devices
A formulation for an inhaler device comprises carrier particles having a diameter of at least 50 μm and a mass median diameter of at least 175 μm; active particles; and additive material to which i...
|
|
|
8178078 |
Compositions containing a solvated active agent suitable for dispensing as a compressed gas aerosol
A composition for solvating one or more active agents in an aqueous solution which is suitable for dispensing as a compressed gas aerosol composition is disclosed. The composition includes at least...
|
|
|
8173107 |
Delivery of antipsychotics through an inhalation route
The present invention relates to the delivery of antipsychotics through an inhalation route. Specifically, it relates to aerosols containing antipsychotics that are used in inhalation therapy. In a...
|
|
|
8158109 |
Foamable suspension gel
The present subject matter provides foamable suspension gels that foam after release from a container. The foamable suspension gels contain at least one pharmaceutically active agent that is...
|
|
|
8158110 |
Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease
The present invention relates to methods and compositions for prevention of graft rejection in lung transplant recipients and for treatment of subjects with pulmonary disorders. Specifically, the...
|
|
|
8142763 |
Pressurized metered dose inhalers (MDI) containing a solution comprising ipratropium bromide, HFA propellant, and co-solvent and comprising a container with a specific internal surface composition and/or lining
The invention relates to pressurized metered dose inhalers (MDIs) in which all or part of the internal surface is stainless steel, anodized aluminum, or lined with an inert organic coating and...
|
|
|
8137657 |
Carrier particles for use in dry powder inhalers
In a method of producing particles suitable for use as carrier particles in dry powder inhalers, particles (1) of a size suitable for use as carrier particles in dry powder inhalers are treated so...
|
|
|
8128910 |
Pesticidal aerosol composition
A pesticidal aerosol composition, containing 3-phenoxybenzyl ester compound represented by Formula (I): wherein, X represents a hydrogen atom or a cyano group; Z represents a hydrogen atom or a...
|
|
|
8124057 |
Propellant-based nanoparticulate dry powder aerosols and method of making
There invention discloses aqueous dispersions of nanoparticulate aerosol formulations, dry powder nanoparticulate aerosol formulation, propellant-based aerosol formulations, methods of using the...
|
|
|
8119106 |
Foamable iodine compositions
The present invention is related to a foamable composition of matter comprising iodine, water, a foam adjuvant, a surface-active agent and a gelling agent. This foamable composition, which may be...
|